New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 10, 2014
08:59 EDTPRANPrana Biotechnology mentioned cautiously at Summer Street
Summer Street said it believes Prana Biotechnology 's PBT2 is a "long shot" as a treatment for Alzheimer’s and Huntington’s diseases. The firm is skeptical about PBT2's proposed mechanism. Shares of Prana are trading down 57c to $9.35 in pre-market trading.
News For PRAN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 13, 2014
11:47 EDTPRANPrana founder claims breakthrough Alzheimer's approach, FierceBiotech says
The scientific founder of Prana Biotechnology, Massachusetts General Hospital investigator Rudy Tanzi, is asserting that he and his fellow researchers have come upon a new approach to growing brain cells in the lab that promises to "revolutionize" Alzheimer's research, reported FierceBiotech. Tanzi is the co-founding scientist and Chief Scientific Adviser at Prana. Reference Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use